Dual Topoisomerase I / II Inhibitors in Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|3|3|339-353

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.3, Iss.3, 2003-01, pp. : 339-353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs

By  

Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. : 4270-4290

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. : 305-320

Bentham Science Publishers

Access to resources Recommend Favorite

Dual Topoisomerase I/II Poisons as Anticancer Drugs

By Denny W.A.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1845-1852

Informa Healthcare

Access to resources Recommend Favorite

Cancer Resistance to Type II Topoisomerase Inhibitors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 23, 2012-08 ,pp. : 3900-3906

Bentham Science Publishers

Access to resources Recommend Favorite

Phase I/II RAF kinase inhibitors in cancer therapy

By Turajlic Samra   Ali Zohra   Yousaf Nadia   Larkin James  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 739-749

Informa Healthcare

Access to resources Recommend Favorite